Two organizations representing patients have demanded a common system of price-fixing for new drugs in Europe.
Tired of the continuous debate over the increasingly high cost of medications, 2 organizations representing patients have demanded a common system of price-fixing for new drugs in Europe. The 2 organizations, the European Patients Forum and the European Organisation for Rare Diseases, have called for a common payment formula for all European nations, rather than have each nation develop it's own nationalized payment and reimbursement scheme. The thought behind the demand is that the united front presented by multiple nations would have a better bargaining power, which would reduce the drug developer's profits.
The groups want a radical new system to ensure patients have access to new medicines without compromising on the sustainability of healthcare systems.
Complete article on Politico: http://politi.co/1IW7H2F
Eye Changes After Cataract Surgery Associated With Diabetic Retinopathy
December 11th 2023Patients receiving uncomplicated phacoemulsification surgery for cataracts had greater increases in macular and choroidal thickness if they had early diabetic retinopathy without preoperative diabetic macular edema.
Read More
Results Show Strong Responses for Brentuximab Vedotin Plus Nivolumab Combo in Patients With cHL
December 11th 2023Use of an antibody drug conjugate and a PD-1 inhibitor brings complementary mechanisms together while eliminating the most toxic agent that has been used in combinations to treat classic Hodgkin lymphoma (cHL).
Read More
ICYMI: Highlights From the ACCC Fall National Oncology Conference
December 11th 2023This year’s top content from the fall meeting of the Association of Community Cancer Centers (ACCC) highlights both treatment gains made through innovative referral, screening, and assistance initiatives and the ongoing need to improve health equity and research inclusivity.
Read More